Your session is about to expire
← Back to Search
Hormone Therapy
Cetrorelix Acetate + Testosterone gel for Healthy Subjects
N/A
Waitlist Available
Led By Joel K Shoemaker, Ph.D.
Research Sponsored by Western University, Canada
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up after 7 days gnrh antagonist alone and 7 days gnrh antagonist + testosterone
Awards & highlights
Summary
This trial will look at the effects of testosterone on the autonomic nervous system (which controls involuntary body functions like heart rate) and blood vessels in men.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ after 7 days gnrh antagonist alone and 7 days gnrh antagonist + testosterone
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~after 7 days gnrh antagonist alone and 7 days gnrh antagonist + testosterone
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Endothelial function
Forearm blood flow
Muscle sympathetic nerve activity
Secondary outcome measures
Skeletal muscle microvascular blood flow
Other outcome measures
Sex hormones
Trial Design
2Treatment groups
Experimental Treatment
Group I: GnRH antagonist aloneExperimental Treatment1 Intervention
Intervention: Cetrorelix acetate (Cetrotide)
Group II: GnRH antagonist + Testosterone add-backExperimental Treatment2 Interventions
Intervention: Cetrorelix acetate (Cetrotide) + Testosterone gel (Androgel)
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Testosterone
FDA approved
Find a Location
Who is running the clinical trial?
Western University, CanadaLead Sponsor
243 Previous Clinical Trials
57,555 Total Patients Enrolled
Joel K Shoemaker, Ph.D.Principal InvestigatorUniversity of Western Ontario, Canada
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- You have diabetes.You have high blood pressure.You currently smoke cigarettes.You currently use opioids or cannabis.You have a medical condition where your body does not produce enough sex hormones.You have Parkinson's disease.You have heart or blood vessel problems.You do not have any long-term health problems.You should be able to move around and do daily activities without much difficulty.You have an addiction to drugs or alcohol.
Research Study Groups:
This trial has the following groups:- Group 1: GnRH antagonist alone
- Group 2: GnRH antagonist + Testosterone add-back
Awards:
This trial has 3 awards, including:- Approved for 10 Other Conditions - This treatment demonstrated efficacy for 10 other conditions.
- All Individual Drugs Already Approved - Therapies where all constituent drugs have already been approved are likely to have better-understood side effect profiles.
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger